MDxHealth S.A.
$0.18-$0.01 (-5.63%)
MDxHealth S.A.’s quoted price sits in the lower half of its reported 52-week range, 96.36% below the high.
OTC · CDXFF · USD
Stock price, earnings
Quote as of Jun 6, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Cloud DX Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Cloud DX Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Cloud DX Inc. is primarily engaged in providing remote patient monitoring (RPM) services. Its central product, Cloud DX Connected Health, functions as a complete virtual healthcare platform. This system facilitates the remote oversight of individuals dealing with long-term conditions such as chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF), patients recovering from surgical procedures, and those rehabilitating from COVID-19 outside of traditional hospital environments. The associated Cloud DX Connected Health Kits feature proprietary devices, including a Bluetooth-enabled pulse oximeter and a wireless weight scale. Clients also have the flexibility to incorporate supplemental third-party devices, such as a wireless Bluetooth blood pressure monitor, a digital thermometer, and a digital wireless glucose meter. Cloud DX caters to a diverse client base in Canada, which includes academic institutions, major hospitals, and provincial health authorities. In the United States, its services extend to physician practices and hospitals. Additionally, the company offers VITALITI, a sophisticated vital sign monitor designed to measure an array of physiological data points. These encompass electrocardiograph readings, heart rate, blood oxygen saturation, respiratory rate, core body temperature, and blood pressure, along with movement, steps taken, and posture. Cloud DX Inc. maintains its corporate headquarters in Brooklyn, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.18-$0.01 (-5.63%)
MDxHealth S.A.’s quoted price sits in the lower half of its reported 52-week range, 96.36% below the high.
$0.33-$0.03 (-8.71%)
Nurosene Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.73% below the high.
$0.22-$0.00 (-0.19%)
Antibe Therapeutics Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.19% below the high.
$0.08$0.00 (0.0%)
LexaGene Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.58% below the high.
$0.08$0.00 (0.0%)
RIV Capital Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.66% below the high.
$0.01-$0.00 (-14.89%)
Bionomics Limited’s quoted price sits in the lower half of its reported 52-week range, 89.09% below the high.
$0.50+$0.48 (+2,269.67%)
HealthBeacon plc’s quoted price sits in the lower half of its reported 52-week range, 82.76% below the high.
$0.03+$0.03 (0.0%)
Carebook Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.51% below the high.